Danny Jones Podcast
Episode overview

#396 - “Ozempic on Steroids” Next Wave of Miracle Peptides Is Coming | Mark Bell

Danny Jones Podcast · 4 Egleze moments
#396 - “Ozempic on Steroids” Next Wave of Miracle Peptides Is Coming | Mark Bell
Episode summary

On this episode of the Danny Jones Podcast, host Danny Jones sits down with Mark Bell, powerlifter, inventor of the Slingshot, and host of the Power Project podcast, for a wide-ranging conversation on performance-enhancing drugs, nutrition, training philosophy, and unconventional health practices. Bell made headlines by confessing to a 25-year testosterone addiction he expects will last his lifetime, citing fears that stopping would cost him mental clarity and training performance despite knowing the health risks. The discussion dove deep into steroid culture, with Bell addressing bodybuilding myths like trenbolone causing homosexual urges due to extreme libido spikes, and explaining how performance drugs alter brain chemistry in unpredictable ways. Bell challenged mainstream diet narratives by claiming dietary fat, not carbohydrates, is the primary obesity driver because of calorie density and restaurant cooking practices that make fat overconsumption unavoidable. He introduced research on WVE-007, the so-called James Bond peptide, which early trials show adds 8 pounds of muscle while cutting visceral fat with only yearly injections. The episode also covered kratom regulation, with Bell's brother reporting Florida's 7-OH ban caused opioid overdose spikes as pain patients turned to fentanyl instead of prescribed alternatives. Bell and Jones discussed GLP-1 drugs like Ozempic, assisted suicide commercials, the importance of outdoor movement and sunlight exposure, homeschooling alternatives like Acton Academy, and Bell's philosophy of equanimity in the face of social media chaos. The conversation blended personal vulnerability with controversial health claims, offering insight into the mind of a fitness influencer who lives at the extreme edge of biohacking.

Key points
Watch original episode More from Danny Jones Podcast

4 moments from this episode

Source-linked · editorially selected
01
Health, Longevity & Biohacking

Mark Bell Reveals 25-Year Testosterone Addiction Will Last Lifetime

Mark Bell candidly admitted to a 25-year testosterone dependency on Danny Jones' podcast, acknowledging he's psychologically and physically addicted. He explained that despite knowing the risks and considering coming off, he fears losing the mental clarity, positivity, and training performance the drugs provide. Bell's admission offers rare transparency about long-term steroid use among fitness influencers.

Read this moment →
02
Health, Longevity & Biohacking

Trenbolone Steroid Linked to Homosexual Urges Among Bodybuilders Community

Bell discussed a longstanding bodybuilding community claim that the steroid trenbolone causes homosexual behavior due to extreme libido spikes. While noting it's an urban legend, he suggested the drug's ability to create uncontrollable sexual urges may lead users toward any outlet. The conversation highlighted how performance-enhancing drugs can radically alter brain chemistry and sexual behavior.

Read this moment →
03
Health, Longevity & Biohacking

Bell Claims Fat Not Carbs Main Driver of Obesity Crisis

Contradicting popular low-carb narratives, Mark Bell argued dietary fat is the primary obesity culprit because calorie density and restaurant cooking practices make fat overconsumption unavoidable. He noted even 93/7 lean ground beef contains 32 grams of fat per pound, and restaurant chefs use excessive oils on all dishes. Bell's position challenges keto and carnivore diet orthodoxy within the fitness community.

Read this moment →
04
Health, Longevity & Biohacking

New WVE-007 Peptide Adds 8 Pounds Muscle While Cutting Fat

Bell revealed research on WVE-007, nicknamed the James Bond peptide, showing dramatic body recomposition effects in early trials: subjects gained 8 pounds of muscle and lost significant visceral fat with only one or two yearly injections. The peptide represents a potential breakthrough in obesity treatment that preserves or builds muscle unlike GLP-1 drugs like Ozempic.

Read this moment →